|
Volumn 145, Issue 47, 2003, Pages 38-41
|
Atrial Fibrillation as the Endpoint of Hypertension;Vorhofflimmern als Endpunkt der Hypertonie
|
Author keywords
Atrial fibrillation; Hypertension; Risk factors
|
Indexed keywords
AMIODARONE;
ANGIOTENSIN ANTAGONIST;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARVEDILOL;
COUMARIN ANTICOAGULANT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOFETILIDE;
SOTALOL;
ANTICOAGULATION;
AUTONOMIC NERVOUS SYSTEM;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
DISEASE ASSOCIATION;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEART MUSCLE CELL;
HEART VENTRICLE REMODELING;
HUMAN;
HYPERTENSION;
MALE;
MORBIDITY;
MORTALITY;
PATHOPHYSIOLOGY;
PRIMARY PREVENTION;
RISK ASSESSMENT;
SHORT SURVEY;
STROKE;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
ATRIAL FIBRILLATION;
COUMARINS;
CROSS-SECTIONAL STUDIES;
GERMANY;
HUMANS;
HYPERTENSION;
INTRACRANIAL EMBOLISM;
RISK FACTORS;
VENTRICULAR REMODELING;
|
EID: 0345714718
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (0)
|